{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:10:36Z","timestamp":1793423436786,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000996","name":"Department of Foreign Affairs and Trade, Australian Government","doi-asserted-by":"publisher","award":["74431"],"award-info":[{"award-number":["74431"]}],"id":[{"id":"10.13039\/501100000996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Molecular mechanisms determining the transmission and prevalence of drug resistant tuberculosis (DR-TB) in Papua New Guinea (PNG) are poorly understood. We used genomic and drug susceptibility data to explore the evolutionary history, temporal acquisition of resistance and transmission dynamics of DR-TB across PNG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed whole genome sequencing on isolates from Central Public Health Laboratory, PNG, collected 2017\u20132019. Data analysis was done on a composite dataset that also included 100 genomes previously sequenced from Daru, PNG (2012\u20132015).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sampled isolates represented 14 of the 22 PNG provinces, the majority (66\/94; 70%) came from the National Capital District (NCD). In the composite dataset, 91% of strains were Beijing 2.2.1.1, identified in 13 provinces. Phylogenetic tree of Beijing strains revealed two clades, Daru dominant clade (A) and NCD dominant clade (B). Multi-drug resistance (MDR) was repeatedly and independently acquired, with the first MDR cases in both clades noted to have emerged in the early 1990s, while fluoroquinolone resistance emerged in 2009 (95% highest posterior density 2000\u20132016). We identified the presence of a frameshift mutation within Rv0678 (p.Asp47fs) which has been suggested to confer resistance to bedaquiline, despite no known exposure to the drug. Overall genomic clustering was significantly associated with <jats:italic>rpoC<\/jats:italic> compensatory and <jats:italic>inhA<\/jats:italic> promoter mutations (p\u2009&lt;\u20090.001), with high percentage of most genomic clusters (12\/14) identified in NCD, reflecting its role as a potential national amplifier.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The acquisition and evolution of drug resistance among the major clades of Beijing strain threaten the success of DR-TB treatment in PNG. With continued transmission of this strain in PNG, genotypic drug resistance surveillance using whole genome sequencing is essential for improved public health response to outbreaks. With occurrence of resistance to newer drugs such as bedaquiline, knowledge of full drug resistance profiles will be important for optimal treatment selection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07414-2","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T18:28:58Z","timestamp":1651861738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea"],"prefix":"10.1186","volume":"22","author":[{"given":"Arnold","family":"Bainomugisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Lavu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Banamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan","family":"Coin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"du Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"7414_CR1","volume-title":"WHO | Global tuberculosis report 2019","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO | Global tuberculosis report 2019. Geneva: World Health Organization; 2020."},{"key":"7414_CR2","unstructured":"Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"7414_CR3","unstructured":"WHO. WHO announces updated definitions of extensively drug-resistant tuberculosis. 2021. https:\/\/www.who.int\/news\/item\/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis. Accessed 27 Jan 2021."},{"key":"7414_CR4","doi-asserted-by":"publisher","first-page":"e0149806","DOI":"10.1371\/journal.pone.0149806","volume":"11","author":"P Aia","year":"2016","unstructured":"Aia P, Kal M, Lavu E, John LN, Johnson K, Coulter C, et al. The burden of drug-resistant tuberculosis in Papua New Guinea: results of a large population-based survey. PLoS ONE. 2016;11:e0149806.","journal-title":"PLoS ONE"},{"key":"7414_CR5","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.5588\/pha.19.0005","volume":"9","author":"EK Lavu","year":"2019","unstructured":"Lavu EK, Johnson K, Banamu J, Pandey S, Carter R, Coulter C, et al. Drug-resistant tuberculosis diagnosis since Xpert\u00ae MTB\/RIF introduction in Papua New Guinea, 2012\u20132017. Public Health Action. 2019;9:S12\u20138.","journal-title":"Public Health Action"},{"key":"7414_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3201\/eid2503.181003","volume":"25","author":"A Bainomugisa","year":"2019","unstructured":"Bainomugisa A, Pandey S, Donnan E, Simpson G, Foster J, Lavu E, et al. Cross-border movement of highly drug-resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through torres strait protected zone, 2010\u20132015. Emerg Infect Dis. 2019;25:406.","journal-title":"Emerg Infect Dis"},{"key":"7414_CR7","first-page":"e000147","volume":"4","author":"A Bainomugisa","year":"2018","unstructured":"Bainomugisa A, Lavu E, Hiashiri S, Majumdar S, Honjepari A, Moke R, et al. Multi-clonal evolution of multi-drug-resistant\/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades. Microb Genomics. 2018;4:e000147.","journal-title":"Microb Genomics"},{"key":"7414_CR8","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment. Online annexes. WHO report","author":"WHO","year":"2020","unstructured":"WHO. WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment. Online annexes. WHO report. Geneva: World Health Organization; 2020."},{"key":"7414_CR9","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320.","journal-title":"Bioinformatics"},{"key":"7414_CR10","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Making the leap: Maq to BWA. Mass Genomics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"7414_CR11","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25:2078\u20139.","journal-title":"Bioinformatics"},{"key":"7414_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"7414_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff. Fly (Austin). 2012;6:80\u201392.","journal-title":"Fly (Austin)"},{"key":"7414_CR14","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.ijmyco.2016.09.062","volume":"5","author":"DM Cirillo","year":"2016","unstructured":"Cirillo DM, Miotto P, Tagliani E. Reaching consensus on drug resistance conferring mutations. Int J Mycobacteriol. 2016;5:S31\u20132.","journal-title":"Int J Mycobacteriol"},{"key":"7414_CR15","doi-asserted-by":"publisher","first-page":"e1001880","DOI":"10.1371\/journal.pmed.1001880","volume":"12","author":"KA Cohen","year":"2015","unstructured":"Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, et al. Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal. PLoS Med. 2015;12:e1001880.","journal-title":"PLoS Med"},{"key":"7414_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng.1038","volume":"44","author":"I Comas","year":"2012","unstructured":"Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M, et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet. 2012;44:106\u201310.","journal-title":"Nat Genet"},{"key":"7414_CR17","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1038\/ncomms5812","volume":"5","author":"F Coll","year":"2014","unstructured":"Coll F, McNerney R, Guerra-Assun\u00e7\u00e3o JA, Glynn JR, Perdig\u00e3o J, Viveiros M, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun. 2014;5:4812.","journal-title":"Nat Commun"},{"key":"7414_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13073-020-00726-5","volume":"12","author":"M Merker","year":"2020","unstructured":"Merker M, Kohl TA, Barilar I, Andres S, Fowler PW, Chryssanthou E, et al. Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex. Genome Med. 2020;12:27.","journal-title":"Genome Med"},{"key":"7414_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nmeth.4285","volume":"14","author":"S Kalyaanamoorthy","year":"2017","unstructured":"Kalyaanamoorthy S, Minh BQ, Wong TKF, Von Haeseler A, Jermiin LS. ModelFinder: Fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14:587\u20139.","journal-title":"Nat Methods"},{"key":"7414_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/molbev\/msu300","volume":"32","author":"LT Nguyen","year":"2015","unstructured":"Nguyen LT, Schmidt HA, Von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32:268\u201374.","journal-title":"Mol Biol Evol"},{"key":"7414_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/molbev\/mst024","volume":"30","author":"BQ Minh","year":"2013","unstructured":"Minh BQ, Nguyen MAT, Von Haeseler A. Ultrafast approximation for phylogenetic bootstrap. Mol Biol Evol. 2013;30:1188\u201395.","journal-title":"Mol Biol Evol"},{"key":"7414_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.3195","volume":"47","author":"M Merker","year":"2015","unstructured":"Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet. 2015;47:242\u20139.","journal-title":"Nat Genet"},{"key":"7414_CR23","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/molbev\/mss075","volume":"29","author":"AJ Drummond","year":"2012","unstructured":"Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29:1969\u201373.","journal-title":"Mol Biol Evol"},{"key":"7414_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1473-3099(12)70277-3","volume":"13","author":"TM Walker","year":"2013","unstructured":"Walker TM, Ip CLC, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis. 2013;13:137\u201346.","journal-title":"Lancet Infect Dis"},{"key":"7414_CR25","doi-asserted-by":"publisher","first-page":"e1008067","DOI":"10.1371\/journal.ppat.1008067","volume":"15","author":"F Menardo","year":"2019","unstructured":"Menardo F, Duch\u00eane S, Brites D, Gagneux S. The molecular clock of mycobacterium tuberculosis. PLoS Pathog. 2019;15:e1008067.","journal-title":"PLoS Pathog"},{"key":"7414_CR26","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.r-project.org\/."},{"key":"7414_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41588-018-0117-9","volume":"50","author":"KE Holt","year":"2018","unstructured":"Holt KE, McAdam P, Thai PVK, Thuong NTT, Ha DTM, Lan NN, et al. Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam. Nat Genet. 2018;50:849\u201356.","journal-title":"Nat Genet"},{"key":"7414_CR28","volume-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment","author":"WHO","year":"2019","unstructured":"WHO. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019."},{"key":"7414_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ng.2656","volume":"45","author":"CB Ford","year":"2013","unstructured":"Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet. 2013;45:784\u201390.","journal-title":"Nat Genet"},{"key":"7414_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/mmi.12476","volume":"91","author":"H Ando","year":"2014","unstructured":"Ando H, Miyoshi-Akiyama T, Watanabe S, Kirikae T. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis. Mol Microbiol. 2014;91:538\u201347.","journal-title":"Mol Microbiol"},{"key":"7414_CR31","doi-asserted-by":"publisher","first-page":"1902383","DOI":"10.1183\/13993003.02383-2019","volume":"55","author":"C Nimmo","year":"2020","unstructured":"Nimmo C, Millard J, Brien K, Moodley S, Van Dorp L, Lutchminarain K, et al. Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients. Eur Respir J. 2020;55:1902383.","journal-title":"Eur Respir J"},{"key":"7414_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12916-019-1487-2","volume":"18","author":"M Klopper","year":"2020","unstructured":"Klopper M, Heupink TH, Hill-Cawthorne G, Streicher EM, Dippenaar A, De Vos M, et al. A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic. BMC Med. 2020;18:24.","journal-title":"BMC Med"},{"key":"7414_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1099\/jmm.0.05343-0","volume":"53","author":"SV Ramaswamy","year":"2004","unstructured":"Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol. 2004;53:107\u201313.","journal-title":"J Med Microbiol"},{"key":"7414_CR34","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1128\/AAC.06418-11","volume":"56","author":"A Poudel","year":"2012","unstructured":"Poudel A, Nakajima C, Fukushima Y, Suzuki H, Pandey BD, Maharjan B, et al. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal. Antimicrob Agents Chemother. 2012;56:2831\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"7414_CR35","doi-asserted-by":"publisher","first-page":"e104100","DOI":"10.1371\/journal.pone.0104100","volume":"9","author":"FAD De Freitas","year":"2014","unstructured":"De Freitas FAD, Bernardo V, Gomgnimbou MK, Sola C, Siqueira HR, Pereira MAS, et al. Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil. PLoS ONE. 2014;9:e104100.","journal-title":"PLoS ONE"},{"key":"7414_CR36","first-page":"1440","volume":"13","author":"M Kourout","year":"2009","unstructured":"Kourout M, Chaoui I, Sabouni R, Lahlou O, El Mzibri M, Jordaan A, et al. Molecular characterisation of rifampicin-resistant mycobacterium tuberculosis strains from morocco. Int J Tuberc Lung Dis. 2009;13:1440\u20132.","journal-title":"Int J Tuberc Lung Dis"},{"key":"7414_CR37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/ng.2747","volume":"45","author":"MR Farhat","year":"2013","unstructured":"Farhat MR, Shapiro BJ, Kieser KJ, Sultana R, Jacobson KR, Victor TC, et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet. 2013;45:1183\u20139.","journal-title":"Nat Genet"},{"key":"7414_CR38","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1128\/IAI.70.9.4955-4960.2002","volume":"70","author":"AS Pym","year":"2002","unstructured":"Pym AS, Saint-Joanis B, Cole ST. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun. 2002;70:4955\u201360.","journal-title":"Infect Immun"},{"key":"7414_CR39","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1128\/JB.180.9.2459-2467.1998","volume":"180","author":"L Miesel","year":"1998","unstructured":"Miesel L, Weisbrod TR, Marcinkeviciene JA, Bittman R, Jacobs WR. NADH dehydrogenase defects confer isoniazid resistance and conditional-lethality in Mycobacterium smegmatis. J Bacteriol. 1998;180:2459\u201367.","journal-title":"J Bacteriol"},{"key":"7414_CR40","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1128\/AAC.49.2.708-720.2005","volume":"49","author":"C Vilch\u00e8ze","year":"2005","unstructured":"Vilch\u00e8ze C, Weisbrod TR, Chen B, Kremer L, Hazb\u00f3n MH, Wang F, et al. Altered NADH\/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother. 2005;49:708\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"7414_CR41","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","volume":"286","author":"T Yano","year":"2011","unstructured":"Yano T, Kassovska-Bratinova S, Shin Teh J, Winkler J, Sullivan K, Isaacs A, et al. Reduction of clofazimine by mycobacterial type 2 NADH: quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem. 2011;286:10276\u201387.","journal-title":"J Biol Chem"},{"key":"7414_CR42","doi-asserted-by":"publisher","first-page":"e102135","DOI":"10.1371\/journal.pone.0102135","volume":"9","author":"K Andries","year":"2014","unstructured":"Andries K, Villellas C, Coeck N, Thys K, Gevers T, Vranckx L, et al. Acquired resistance of Mycobacterium tuberculosis to bedaquiline. PLoS ONE. 2014;9:e102135.","journal-title":"PLoS ONE"},{"key":"7414_CR43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1183\/09031936.00142914","volume":"45","author":"A Somoskovi","year":"2015","unstructured":"Somoskovi A, Bruderer V, H\u00f6mke R, Bloemberg GV, B\u00f6ttger EC. A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment. Eur Respir J. 2015;45:554\u20137.","journal-title":"Eur Respir J"},{"key":"7414_CR44","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1128\/AAC.01197-08","volume":"53","author":"V Mathys","year":"2009","unstructured":"Mathys V, Wintjens R, Lefevre P, Bertout J, Singhal A, Kiass M, et al. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2009;53:2100\u20139.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07414-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07414-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07414-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T23:03:55Z","timestamp":1651878235000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07414-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7414"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07414-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board, PNG Medical Research Advisory Committee (MRAC no:20.11) and followed the Declaration of Helsinki Ethical Principles for medical research involving human subjects. The need for informed consent was waived by the PNG Medical Research Advisory Committee (MRAC no:20.11).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}